76
42
Growth Score
-7 pts
Heat Score
-1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
1075350
SipNose develops an innovative nasal delivery device for local, systemic, and central nervous system indications.
- Iris Shichor: CEO and Co-Founder
- Daniel Shahaf: Co-Founder and CTO
About the Company
SipNose develops an innovative nasal delivery device for local, systemic, and central nervous system indications. The company's flexible solution is suitable for clinical or home use, for daily or emergency administration, for pediatric, adult, and geriatric patients. The company's devices allows new treatments for a wide variety of
neurological disorders.
Founded in 2011, SipNose collaborates with worldwide pharmaceutical and biopharmaceutical companies. It is headquartered in Yoqne`am `illit, Israel.
